Details

Application number :
46815  
Application type :
Standard  
Application status :
CEASED  
Under opposition :
No  
Proceeding type :
 
Invention title :
Pegylated interferon alfa-CCR5 antagonist combination HIV therapy  
Inventor :
Laughlin, Mark A.  
Agent name :
Griffith Hack  
Address for service :
GPO Box 4164 SYDNEY NSW 2001  
Filing date :
01 May 2000  
Associated companies :
 
Applicant name :
Schering Corporation  
Applicant address :
2000 Galloping Hill Road Kenilworth NJ 07033-0530 United States Of America  
Old name :
 
Original Source :
Go  

Same Inventor